Form 4: Guardant Health Director Steve Krognes Reports Stock Transaction
SEC Form 4 Filing
Director Steve Krognes reports a transaction involving Guardant Health, Inc. common stock related to the vesting of restricted stock units.
Summary
- On October 31, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving the company's common stock.
- The transaction involved the vesting of 154 restricted stock units (RSUs) at a price of $0.
- Following the transaction, Krognes directly owns 9,911 shares of Guardant Health common stock and 3,086 derivative securities.
- The RSUs were granted on August 9, 2022, and vest over time.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it involves the vesting of previously granted equity compensation.
Key Dates
| Date | Description |
|---|---|
| 08/09/2022 | Date of restricted stock unit award grant |
| 06/30/2023 | Initial vesting date for 25% of the restricted stock units |
| 10/31/2024 | Date of the reported transaction (vesting of RSUs) |
| 11/04/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.